Retinoblastoma Biomarker Study
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
The Incidence of Breast and Other Cancers Among Female Flight Attendants
- Status
- COMPLETED
- Phase
- N/A
Molecular Epidemiology of Cutaneous Malignant Melanoma
- Status
- COMPLETED
- Phase
- N/A
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
- Status
- COMPLETED
- Phase
- N/A
Genetic Analysis of Familial Melanoma
- Status
- COMPLETED
- Phase
- N/A
Family Study of Melanoma in Italy
- Status
- COMPLETED
- Phase
- N/A
Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Randomised Study to Compare the Efficacy of AZD6244 vs TMZ
- Status
- COMPLETED
- Phase
- PHASE2
Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety of TKI258 in Advanced/Metastatic Melanoma Subjects
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
- Status
- COMPLETED
- Phase
- NA
Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Single Arm Study of Ipilimumab Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Talimogene Laherparepvec in Stage IIIc and Stage IV Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study for the Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Multicenter Selective Lymphadenectomy Trial (MSLT)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Intravenous INO-1001 Plus Oral Temozolomide to Evaluate Tolerability, Safety, and Pharmacokinetics in Patients With Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
TNFerade™ Biologic Plus Radiation for Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2